Literature DB >> 29377001

Partial DNA-guided Cas9 enables genome editing with reduced off-target activity.

Hao Yin1, Chun-Qing Song2, Sneha Suresh1, Suet-Yan Kwan2, Qiongqiong Wu1, Stephen Walsh1, Junmei Ding1, Roman L Bogorad1, Lihua Julie Zhu3,4,5, Scot A Wolfe3,6, Victor Koteliansky7, Wen Xue2,3,5, Robert Langer1,8,9,10, Daniel G Anderson1,8,9,10.   

Abstract

CRISPR-Cas9 is a versatile RNA-guided genome editing tool. Here we demonstrate that partial replacement of RNA nucleotides with DNA nucleotides in CRISPR RNA (crRNA) enables efficient gene editing in human cells. This strategy of partial DNA replacement retains on-target activity when used with both crRNA and sgRNA, as well as with multiple guide sequences. Partial DNA replacement also works for crRNA of Cpf1, another CRISPR system. We find that partial DNA replacement in the guide sequence significantly reduces off-target genome editing through focused analysis of off-target cleavage, measurement of mismatch tolerance and genome-wide profiling of off-target sites. Using the structure of the Cas9-sgRNA complex as a guide, the majority of the 3' end of crRNA can be replaced with DNA nucleotide, and the 5 - and 3'-DNA-replaced crRNA enables efficient genome editing. Cas9 guided by a DNA-RNA chimera may provide a generalized strategy to reduce both the cost and the off-target genome editing in human cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29377001      PMCID: PMC5902734          DOI: 10.1038/nchembio.2559

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  48 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Crystal structure of A. aeolicus argonaute, a site-specific DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage.

Authors:  Yu-Ren Yuan; Yi Pei; Jin-Biao Ma; Vitaly Kuryavyi; Maria Zhadina; Gunter Meister; Hong-Ying Chen; Zbigniew Dauter; Thomas Tuschl; Dinshaw J Patel
Journal:  Mol Cell       Date:  2005-08-05       Impact factor: 17.970

3.  The orientation and dynamics of the C2'-OH and hydration of RNA and DNA.RNA hybrids.

Authors:  J I Gyi; A N Lane; G L Conn; T Brown
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

Review 4.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

5.  Relative thermodynamic stability of DNA, RNA, and DNA:RNA hybrid duplexes: relationship with base composition and structure.

Authors:  E A Lesnik; S M Freier
Journal:  Biochemistry       Date:  1995-08-29       Impact factor: 3.162

6.  DNA-guided DNA interference by a prokaryotic Argonaute.

Authors:  Daan C Swarts; Matthijs M Jore; Edze R Westra; Yifan Zhu; Jorijn H Janssen; Ambrosius P Snijders; Yanli Wang; Dinshaw J Patel; José Berenguer; Stan J J Brouns; John van der Oost
Journal:  Nature       Date:  2014-02-16       Impact factor: 49.962

7.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.

Authors:  Prashant Mali; John Aach; P Benjamin Stranges; Kevin M Esvelt; Mark Moosburner; Sriram Kosuri; Luhan Yang; George M Church
Journal:  Nat Biotechnol       Date:  2013-08-01       Impact factor: 54.908

8.  GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.

Authors:  Shengdar Q Tsai; Zongli Zheng; Nhu T Nguyen; Matthew Liebers; Ved V Topkar; Vishal Thapar; Nicolas Wyvekens; Cyd Khayter; A John Iafrate; Long P Le; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-12-16       Impact factor: 54.908

9.  Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification.

Authors:  John P Guilinger; David B Thompson; David R Liu
Journal:  Nat Biotechnol       Date:  2014-04-25       Impact factor: 54.908

10.  Conjugation and Evaluation of Triazole-Linked Single Guide RNA for CRISPR-Cas9 Gene Editing.

Authors:  Kaizhang He; Eldon T Chou; Shawn Begay; Emily M Anderson; Anja van Brabant Smith
Journal:  Chembiochem       Date:  2016-08-19       Impact factor: 3.164

View more
  43 in total

1.  Very fast CRISPR on demand.

Authors:  Yang Liu; Roger S Zou; Shuaixin He; Yuta Nihongaki; Xiaoguang Li; Shiva Razavi; Bin Wu; Taekjip Ha
Journal:  Science       Date:  2020-06-12       Impact factor: 47.728

Review 2.  Allosteric regulation of CRISPR-Cas9 for DNA-targeting and cleavage.

Authors:  Zhicheng Zuo; Jin Liu
Journal:  Curr Opin Struct Biol       Date:  2020-02-18       Impact factor: 6.809

Review 3.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

Review 4.  Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.

Authors:  Hong-Xia Zhang; Ying Zhang; Hao Yin
Journal:  Mol Ther       Date:  2019-01-25       Impact factor: 11.454

Review 5.  Exploring the Trans-Cleavage Activity of CRISPR-Cas12a (cpf1) for the Development of a Universal Electrochemical Biosensor.

Authors:  Yifan Dai; Rodrigo A Somoza; Liu Wang; Jean F Welter; Yan Li; Arnold I Caplan; Chung Chiun Liu
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-17       Impact factor: 15.336

6.  In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency.

Authors:  Chun-Qing Song; Dan Wang; Tingting Jiang; Kevin O'Connor; Qiushi Tang; Lingling Cai; Xiangrui Li; Zhiping Weng; Hao Yin; Guangping Gao; Christian Mueller; Terence R Flotte; Wen Xue
Journal:  Hum Gene Ther       Date:  2018-05-14       Impact factor: 5.695

Review 7.  CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.

Authors:  Dan Wang; Feng Zhang; Guangping Gao
Journal:  Cell       Date:  2020-04-02       Impact factor: 41.582

8.  Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing.

Authors:  Tuo Wei; Qiang Cheng; Lukas Farbiak; Daniel G Anderson; Robert Langer; Daniel J Siegwart
Journal:  ACS Nano       Date:  2020-07-22       Impact factor: 15.881

9.  Single molecule analysis of effects of non-canonical guide RNAs and specificity-enhancing mutations on Cas9-induced DNA unwinding.

Authors:  Ikenna C Okafor; Digvijay Singh; Yanbo Wang; Minhee Jung; Haobo Wang; John Mallon; Scott Bailey; Jungjoon K Lee; Taekjip Ha
Journal:  Nucleic Acids Res       Date:  2019-12-16       Impact factor: 16.971

Review 10.  CRISPR for Neuromuscular Disorders: Gene Editing and Beyond.

Authors:  Courtney S Young; April D Pyle; Melissa J Spencer
Journal:  Physiology (Bethesda)       Date:  2019-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.